Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FX1WG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $122,843
Award facts
- Contract value 100% obligated
- $122,843.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $122,843.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, issued on May 8, 2025, with an ultimate completion date of May 30, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the SPE2DB program, a $500 million vehicle valid through November 2026 that enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs at military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in Defense Logistics Agency procurement markets. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare systems nationwide. This delivery order for Keytruda, an oncology treatment, exemplifies the company's extensive portfolio of specialty medications and pharmaceutical products supplied to military healthcare facilities, reinforcing its significant role in supporting federal healthcare logistics operations.
Quick answers
Who was awarded contract SPE2DB25FX1WG?
SPE2DB25FX1WG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 8, 2025.
How much is contract SPE2DB25FX1WG worth?
The government has obligated $122,843 on SPE2DB25FX1WG.
Is contract SPE2DB25FX1WG an order under another contract?
Yes. SPE2DB25FX1WG is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1WG competed?
The extent of competition for SPE2DB25FX1WG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award